Deutsche Knochenmarkspenderdatei

Recent papers from Deutsche Knochenmarkspenderdatei

1. The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care modelAnnals of Hematology · 2026
2. Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world studyBritish Journal of Haematology · 2026
3. Comorbid conditions after allogeneic haematopoietic stem cell transplantation in young adults in Germany—A prospective, multicentre trialBritish Journal of Haematology · 2026
4. Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell TransplantationJournal of Clinical Oncology · 2026
5. HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeBone Marrow Transplantation · 2026
6. The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic ContextHLA · 2026
7. The DKMS Access to Transplantation program: Addressing barriers to HSCTBlood Global Hematology · 2026
8. Inclusive Practices for Safe and Equitable Donor AssessmentTransplantation and Cellular Therapy · 2026
9. Haploidentical Allogeneic Cell Transplantation in Relapsed/Refractory Multiple MyelomaCancer Management and Research · 2026
10. PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotypeAnnals of Hematology · 2026
11. Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance inductionJournal of Translational Medicine · 2025
12. Vδ2 unconventional T cells in the donor graft are associated with improved overall survival after unrelated donor allo-HCT for AML and MDS: An analysis from the DKMS and NMDP graft composition studyBlood · 2025
13. Inclusive practices for safe and equitable donor assessmentBlood · 2025
14. Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationNature · 2025
15. Genetic Findings of Potential Donor Origin in Cells Used for Cell and Gene Therapy: Recommendations from the World Marrow Donor AssociationBiology of Blood and Marrow Transplantation · 2025
16. PCR optimization for buccal swab-derived samples: overcoming sporadic inhibition with bovine serum albuminBMC Genomics · 2025
17. FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid LeukemiaCancer Research · 2025
18. Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo‐Controlled Phase 2 DELTA TrialAmerican Journal of Hematology · 2025
19. Bridging XLUUV and MASS – Technologies for Autonomous Multi-Domain OperationsJournal of Physics Conference Series · 2025
20. Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health StrategyClinical Transplantation · 2025